HPV 16/18 positivity

There are 3 papers on HPV 16/18 positivity in aging research: 3 observational studies in people.

Biomarker

3 papers study it1 more mentions it1 finding

2 new papers in 30 daysSee all 4 papers on HPV 16/18 positivity

“Three-year cumulative CIN2+ risk was 20.9% (15.2-28.1) for HPV 16/18-positive women, 6.6% (4.9-8.9) for other types, and 0.1% (0.04-0.2) for HPV-negative women.”
HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from ChinaJournal of clinical microbiology2026doi:10.1128/jcm.01289-25
  • Humans3

Associations

1

Cervical intraepithelial neoplasia grade 2 or worse

upin humans1

1 study
  1. HPV 16/18 positivity predicts cervical intraepithelial neoplasia grade 2 or worse in humans (normal cytology) (Three-year cumulative risk: 20.9% (95% CI 15.2–28.1) for HPV 16/18-positive women versus 0.1% (0.04–0.2) for HPV-negative women).

    “Three-year cumulative CIN2+ risk was 20.9% (15.2-28.1) for HPV 16/18-positive women, 6.6% (4.9-8.9) for other types, and 0.1% (0.04-0.2) for HPV-negative women.”

    Humansnormal cytology3 yearsfemalesn = 6,679

    HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China

    Journal of clinical microbiology

More on Cervical intraepithelial neoplasia grade 2 or worse

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 24 papers in 12 months